in

More than 65 industry players across the world are presently engaged in evaluating the clinical appl

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this link 

The over USD 5 billion (by 2030) financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across the following segments:

Target Disease Indication

Cancer

Genetic Disorders

Neurological Indications

Others

Route of Administration

Oral

Inhalation

Key Geographies

North America

Europe

Asia-Pacific and the Rest of the World

The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:

GW Pharmaceuticals

Corbus Pharmaceuticals

Tilray

Tetra Bio-Pharma

Botanix Pharmaceuticals

Kalytera Therapeutics

Therapix Biosciences

Echo Pharmaceuticals

Avicanna

GB Sciences

Table of Contents

1.         PREFACE

 

2.         EXECUTIVE SUMMARY

 

3.         INTRODUCTION

 

4.         MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS

 

5.         COMPANY PROFILES

 

6.         ACADEMIC GRANTS ANALYSIS

 

7.         PARTNERSHIPS AND COLLABORATIONS

 

8.         MERGERS AND ACQUISITIONS

 

9.         DRUG DEVELOPMENT STRATEGY ANALYSIS

10.        MARKET FORECAST AND OPPORTUNITY ANALYSIS

 

11.        CONCLUDING REMARKS

 

12.        EXECUTIVE INSIGHTS

 

13.        APPENDIX 1: TABULATED DATA

 

14.        APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

This post was created with our nice and easy submission form. Create your post!

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Loading…

0

What do you think?

Elon Musk Praises Bitcoin, Lauds Chances of Mass Adoption

Elon Pump Sees Twitter-Volumes For Bitcoin Reach New All-Time Highs

The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report features an extensive st